001     182184
005     20241220120852.0
024 7 _ |a 10.1002/eji.202149400
|2 doi
024 7 _ |a pmid:36263815
|2 pmid
024 7 _ |a 0014-2980
|2 ISSN
024 7 _ |a 1521-4141
|2 ISSN
024 7 _ |a altmetric:137465429
|2 altmetric
037 _ _ |a DKFZ-2022-02486
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Madi, Alaa Abdelghani Mohamed
|0 P:(DE-He78)f05eabc961bc296c088b3510d6429d02
|b 0
|e First author
|u dkfz
245 _ _ |a Regulatory T cell-derived interleukin-15 promotes the diversity of immunological memory.
260 _ _ |a Weinheim
|c 2023
|b Wiley-VCH
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1698998584_23211
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:D192#LA:D192# / 2023 Jan;53(1):e2149400 / HI-TRON
520 _ _ |a While the immunosuppressive function of regulatory T (Treg) cells has been extensively studied, their immune-supportive roles have been less well investigated. Using a lymphocytic choriomeningitis virus (LCMV) Armstrong infection mouse model, we found that Treg cell-derived interleukin (IL)-15 is required for long-term maintenance of the KLRG1+ IL-7Rα- CD62L- terminal effector memory CD8+ T (tTEM) cell subset, but dispensable for the suppressive function of Treg cells themselves. In contrast, deletion of Il15 from other sources, including myeloid cells and muscles, did not affect the composition of the memory CD8+ T cell pool. Our findings identify Treg cells as an essential IL-15 source maintaining tTEM cells and suggest that Treg cells promote the diversity of immunological memory. This article is protected by copyright. All rights reserved.
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a IL-15 ⋅ Treg cells ⋅ Effector memory ⋅ T cells
|2 Other
700 1 _ |a Wu, Jingxia
|0 P:(DE-He78)bf88e5f49a614f52ba8ce2cd433e6b41
|b 1
|u dkfz
700 1 _ |a Ma, Sicong
|0 P:(DE-He78)b74df323e3939b563635a2cba7a7afba
|b 2
|u dkfz
700 1 _ |a Weisshaar, Nina
|0 P:(DE-He78)4e185694e1e726dc738bad0a0c41cdd0
|b 3
700 1 _ |a Mieg, Alessa
|0 P:(DE-He78)32b6d84a1ad5f50401b97559993ad65d
|b 4
|u dkfz
700 1 _ |a Hering, Marvin
|0 P:(DE-He78)b099c4255c1bff642f4d338ef157596e
|b 5
|u dkfz
700 1 _ |a Ming, Yanan
|0 P:(DE-He78)8ce8b1ff87fe0b01dfcbdb9d2b22046d
|b 6
|u dkfz
700 1 _ |a Zettl, Ferdinand
|0 P:(DE-He78)a97252706aa90b10eb9e489f0018ba96
|b 7
|u dkfz
700 1 _ |a Mohr, Kerstin
|0 P:(DE-He78)d44688ee76051cbf2318fb62d6dfb9c4
|b 8
|u dkfz
700 1 _ |a Ten Bosch, Nora
|0 P:(DE-He78)ad4b5f19b891aeb51245ce42ff3d92ff
|b 9
|u dkfz
700 1 _ |a Schlimbach, Tilo
|0 P:(DE-He78)f0981e2f445e4057d7b16b07b3317df3
|b 10
700 1 _ |a Hertel, Franziska
|0 P:(DE-He78)470d596989d1c5c31fdaa5a2b638e5ae
|b 11
|u dkfz
700 1 _ |a Cui, Guoliang
|0 P:(DE-He78)0b7ce76033a6756b91f5bfb12602e20b
|b 12
|e Last author
|u dkfz
773 _ _ |a 10.1002/eji.202149400
|g p. eji.202149400
|0 PERI:(DE-600)1491907-2
|n 1
|p e2149400
|t European journal of immunology
|v 53
|y 2023
|x 0014-2980
909 C O |o oai:inrepo02.dkfz.de:182184
|p VDB
|p OpenAPC
|p openCost
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)f05eabc961bc296c088b3510d6429d02
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)bf88e5f49a614f52ba8ce2cd433e6b41
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)b74df323e3939b563635a2cba7a7afba
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)4e185694e1e726dc738bad0a0c41cdd0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)32b6d84a1ad5f50401b97559993ad65d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)b099c4255c1bff642f4d338ef157596e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)8ce8b1ff87fe0b01dfcbdb9d2b22046d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)a97252706aa90b10eb9e489f0018ba96
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)d44688ee76051cbf2318fb62d6dfb9c4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)ad4b5f19b891aeb51245ce42ff3d92ff
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)f0981e2f445e4057d7b16b07b3317df3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)470d596989d1c5c31fdaa5a2b638e5ae
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)0b7ce76033a6756b91f5bfb12602e20b
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2022
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2021-02-02
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-19
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-19
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-19
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J IMMUNOL : 2022
|d 2023-08-19
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EUR J IMMUNOL : 2022
|d 2023-08-19
915 p c |a APC keys set
|2 APC
|0 PC:(DE-HGF)0000
915 p c |a Local Funding
|2 APC
|0 PC:(DE-HGF)0001
920 2 _ |0 I:(DE-He78)D192-20160331
|k D192
|l T-Zell-Metabolismus
|x 0
920 1 _ |0 I:(DE-He78)D192-20160331
|k D192
|l T-Zell-Metabolismus
|x 0
920 0 _ |0 I:(DE-He78)D192-20160331
|k D192
|l T-Zell-Metabolismus
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D192-20160331
980 _ _ |a UNRESTRICTED
980 _ _ |a APC


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21